-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Reata Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2022.
- Reata Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending June 30, 2023 was $285M.
- Reata Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was $265M.
- Reata Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was -$33.9M, a 36.2% increase from 2021.
- Reata Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was -$53.1M, a 21% decline from 2020.
- Reata Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2020 was -$43.9M, a 789% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)